The TED website is eForms-ready since 2.11.2022. The search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages.

Services - 652983-2022

25/11/2022    S228

France-Paris: Health services

2022/S 228-652983

Prior information notice

This notice is for prior information only

Services

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: GIP RESAH
National registration number: FR61130005010
Postal address: 47 rue de Charonne
Town: PARIS
NUTS code: FR France
Postal code: 75011
Country: France
Contact person: Louis Potel
E-mail: l.potel@resah.fr
Telephone: +33 761735053
Internet address(es):
Main address: https://www.resah.fr/
Address of the buyer profile: https://www.resah.fr/
I.1)Name and addresses
Official name: Universitá degli Studi di Napoli Federico II, Department of Public Health (UNINA)
National registration number: IT00876220633
Postal address: via Sergio Pansini, n.5
Town: Naples
NUTS code: IT Italia
Postal code: 80131
Country: Italy
Contact person: Maddalena Illario
E-mail: illario@unina.it
Telephone: +34 943006250
Internet address(es):
Main address: http://www.unina.it/
Address of the buyer profile: http://www.unina.it/
I.1)Name and addresses
Official name: Servicio Vasco de Salud Osakidetza (OSAK)
National registration number: ESS5100023J
Postal address: Calle Alava 45
Town: Vitoria-Gateiz
NUTS code: ES España
Postal code: 01006
Country: Spain
Contact person: MARIAISABEL ARZAMENDISESE
E-mail: MARIAISABEL.ARZAMENDISESE@osakidetza.eus
Internet address(es):
Main address: http://www.osakidetza.euskadi.eus/
Address of the buyer profile: http://www.osakidetza.euskadi.eus/
I.1)Name and addresses
Official name: INSTITUT CATALA D'ONCOLOGIA (ICO)
National registration number: ESQ5856383D
Postal address: Av. Gran Via de l’Hospitalet
Town: Barcelona
NUTS code: ES España
Postal code: ES511
Country: Spain
Contact person: Louis Potel
E-mail: l.potel@resah.fr
Telephone: +33 761735053
Internet address(es):
Main address: https://www.resah.fr/
Address of the buyer profile: https://www.resah.fr/
I.2)Information about joint procurement
The contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law:

Cross-border collaborative procurement between French, Spanish and Italian organisations (see explication in section II.2.14)

I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://radar-ppi.com/
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Innovative solutions for the rapid detection of multi drug resistant microorganisms (MDROs) and the smart management and control of antimicrobial resistance (AMR) - Launch of Open Market Consultation

Reference number: Grant agreement 101036228
II.1.2)Main CPV code
85100000 Health services - RC05
II.1.3)Type of contract
Services
II.1.4)Short description:

The four healthcare buyers of the RaDAR PPI project have identified an unmet need for rapid detection of multi-drug resistant microorganisms (MDROs) and smart antimicrobial resistance (AMR) management and control systems to combat a serious and growing global problem. It is anticipated that these buyers will launch coordinated tenders for the procurement of innovative solutions to address this challenge in Q3 of 2023.This prior information notice has been published to provide early notification that a public procurement of innovation will take place and to launch a period of Open Market Consultation (OMC).The second stage involves five Open Market Consultation events: These events will be in person and online and you are invited to register for these events via the market response form which can be found at : https://radar-ppi.com/procurement/

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES España
NUTS code: FR France
NUTS code: IT Italia
Main site or place of performance:

Resah : FR France

UNINA: ITF3 Campania region

Osak: ES211 Araba

ICO: ES51 for Cataluña region

II.2.4)Description of the procurement:

Hospitals and healthcare units are at the frontline of the battle to detect, manage and control antimicrobial resistance (AMR) among patients and in the clinical environment. While investment in the development of new antibiotics is crucial, another important area where innovation is needed is the rapid detection, management, and control of AMR.

RaDAR aims to address this urgent need for rapid detection and effective infection control systems for AMR, through a public procurement of innovation (PPI). The four healthcare buyers have identified an unmet need for rapid detection of multi-drug resistant microorganisms (MDROs) and antimicrobial resistance management and control systems to combat this serious and growing global problem.

The procurement will be carried out in a collaborative manner by them, GIP Resah will act as lead procurer. The RaDAR PPI buyers' group is composed of: GIP Resah (France), Institut Catala d’Oncologia (Spain),Servicio Vasco de Salud Osakidetza (Spain), Universitá degli Studi di Napoli Federico II, Department of Public Health (Italy). These buyers will launch coordinated tenders for the procurement of innovative solutions to address this challenge in Q3 of 2023. A prior information notice has been published to provide early notification that a public procurement of innovation will take place and that a period of Open Market Consultation (OMC) is going to be launched. The first stage of the OMC is a market sounding : Interested parties are invited to read the market Sounding Prospectus (MSP) and provide feedback via the Market Response Form: https://radar-ppi.com/procurement/

The second stage involves five Open Market Consultation events: these events will be in person and online and you are invited to register for these events via the market response form which can be found at: https://radar-ppi.com/procurement/.

A direct link to the response form can be found at RaDAR Market Response Form

Based on the conclusions of the second stage, a potential third stage of the OMC will be opened to perform bilateral meetings between public buyers and economic operators. In that case, interested parties, market actors and innovation agents will be invited to have bilateral meetings with public buyers after the Open Market Consultation events. Any update on this behalf will be provided in the website https://radar-ppi.com/procurement/

The aim of this open market consultation is to open a dialogue with the supply chain to: Explore what solutions are or could be available given the right market conditions to address the unmet needs and requirements identified by the buyers group (see section 3), Understand the timeframes over which these solutions can be mobilised or become available, Inform the buyers group as to how we can support suppliers and innovators to deliver innovative solutions to meet these needs. The buyers and their expert partners have conducted an initial state of the art review and believe that the supply chain has the information, insights and creativity to address the challenges outlined in the MSP, and are open to all ideas, from all parts of the supply chain, that could contribute to addressing this important challenge area.The feedback from the supply chain will be used to refine the clinical demand of the four buyers and inform the collaborative tender specification and strategy. RaDAR Buyers will conduct a cross-border collaborative procurement of innovation : that each buyer will publish their own call for tenders in their country (1 in France, 1 in Italy and 2 in Spain). 1Common preparatory phase - Buyers worked collaboratively on common needs identification, and are launching this common open market consultation; 2Coordinated publication – Buyers will work on coordinated individual tenders’ preparation per locality so that each buyer procures according to their context and national laws and informed by the outcomes of the OMC.3Coordinated evaluation and awarding of the contract.

II.2.14)Additional information

The second stage involves five Open Market Consultation events: These events will be in person and online and you are invited to register for these events via the market response form which can be found at: https://radar-ppi.com/procurement/.

A direct link to the response form can be found at RaDAR Market Response Form

II.3)Estimated date of publication of contract notice:
22/11/2022

Section IV: Procedure

IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes

Section VI: Complementary information

VI.3)Additional information:

Hospitals and specialist healthcare units are at the frontline of the battle to detect, manage and control antimicrobial resistance (AMR) among patients and in their clinical environment. While investment in the development of new antibiotics is crucial, another important area where innovation is needed is the rapid detection, management, and control of AMR in the healthcare environment.

RaDAR aims to address this urgent need for rapid detection and effective infection control systems for AMR, through a public procurement of innovation (PPI). Four healthcare buyers have identified an unmet need for rapid detection of multi-drug resistant microorganisms (MDROs) and antimicrobial resistance management and control systems to combat this serious and growing global problem.

The procurement will be carried out in a collaborative manner by the organisations of the buyers' group, GIP Réseau des acheteurs hospitaliers (Resah) will act as lead procurer.

As of the date of the publication of this information notice the RaDAR PPI buyers' group is composed of:

- GIP Resah (France)

- Institut Catala d’Oncologia (Spain)

- Servicio Vasco de Salud Osakidetza (Spain)

- Universitá degli Studi di Napoli Federico II, Department of Public Health (Italy)

It is anticipated that these buyers will launch coordinated tenders for the procurement of innovative solutions to address this challenge in Q3 of 2023.

This prior information notice has been published to provide early notification that a public procurement of innovation will take place and that a period of Open Market Consultation (OMC) is going to be launched.

The first stage of the OMC is a market sounding: Interested parties, market actors and innovation agents are invited to read the market Sounding Prospectus (MSP) and provide feedback via the Market Response Form: https://radar-ppi.com/procurement/

The second stage involves five Open Market Consultation events: These events will be in person and online and you are invited to register for these events via the market response form which can be found at: https://radar-ppi.com/procurement/.

A direct link to the response form can be found at RaDAR Market Response Form

Based on the conclusions of the second stage, a potential third stage of the OMC will be opened to perform bilateral meetings between public buyers and economic operators. In that case, interested parties, market actors and innovation agents will be invited to have bilateral meetings with public buyers after the Open Market Consultation events. Any update on this behalf will be provided in the website https://radar-ppi.com/procurement/

The aim of this open market consultation is to open a dialogue with the supply chain to:

- Explore what solutions are or could be available given the right market conditions to address the unmet needs and requirements identified by the buyers group (see section 3)

Understand the timeframes over which these solutions can be mobilised or become available

- Inform the buyers group as to how we can support suppliers and innovators to deliver innovative solutions to meet these needs.

The buyers and their expert partners have conducted an initial state of the art review and believe that the supply chain has the information, insights and creativity to address the challenges outlined in the MSP, and are open to all ideas, from all parts of the supply chain, that could contribute to addressing this important challenge area.

The feedback from the supply chain will be used to refine the clinical demand of the four buyers and inform the collaborative tender specification and strategy.

RaDAR Buyers Group will conduct a cross-border collaborative procurement of innovation, which means that each buyer will publish their own call for tenders in their country (1 call in France, 1 call in Italy and 2 calls in Spain).

VI.5)Date of dispatch of this notice:
21/11/2022